Exit Notice
You are about to leave ClinicalTrials.gov and go to: To obtain contact information for a study center near you, click here. URL: https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6181065&StudyName=Sunitinib%20Malate%20Schedule%204/2%20vs.%20Sunitinib%20Malate%20Continuous%20Dosing%20As%20First-Line%20Therapy%20For%20Metastatic%20Renal%20Cell%20Cancer%20%28RCC%29
Click on the link to continue or return to ClinicalTrials.gov Home